Development of innovative biomaterials and devices for the treatment of cardiovascular diseases

Y Wang, G Li, L Yang, R Luo, G Guo - Advanced Materials, 2022 - Wiley Online Library
Cardiovascular diseases have become the leading cause of death worldwide. The
increasing burden of cardiovascular diseases has become a major public health problem …

Advances in revascularization for peripheral artery disease: revascularization in PAD

JA Beckman, PA Schneider, MS Conte - Circulation research, 2021 - Am Heart Assoc
Effective revascularization of the patient with peripheral artery disease is about more than
the procedure. The approach to the patient with symptom-limiting intermittent claudication or …

A perspective on the wet spinning process and its advancements in biomedical sciences

AR Shirvan, A Nouri, A Sutti - European Polymer Journal, 2022 - Elsevier
Over the past decade, there has been significant growth in the use of fibre-based products
and structures for biomedical applications, with new fibrous materials and manufacturing …

Recent strategies for improving hemocompatibility and endothelialization of cardiovascular devices and inhibition of intimal hyperplasia

LA Feng, J Shi, JY Guo, SF Wang - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
Cardiovascular diseases have become one of the leading causes of mortality worldwide.
Stents and artificial grafts have been used to treat cardiovascular diseases. Thrombosis and …

Biomedical applications of polymer and ceramic coatings: A review of recent developments

JR Smith, DA Lamprou, C Larson… - Transactions of the …, 2022 - Taylor & Francis
Recent literature concerning the use of polymer and ceramic coatings for a variety of
biomedical applications is surveyed in this review. Applications have been grouped into six …

[HTML][HTML] Patterned drug-eluting coatings for tracheal stents based on pla, plga, and pcl for the granulation formation reduction: In vivo studies

OA Sindeeva, ES Prikhozhdenko, I Schurov, N Sedykh… - Pharmaceutics, 2021 - mdpi.com
Expandable metallic stent placement is often the only way to treat airway obstructions. Such
treatment with an uncoated stent causes granulation proliferation and subsequent …

[HTML][HTML] Drug-loaded balloon with built-in NIR controlled tip-separable microneedles for long-effective arteriosclerosis treatment

L Huang, H Fang, T Zhang, B Hu, S Liu, F Lv, Z Zeng… - Bioactive Materials, 2023 - Elsevier
Drug-eluting balloon (DEB) angioplasty has emerged as an effective treatment for
cardiovascular and cerebrovascular diseases. However, distal embolism and late lumen …

[HTML][HTML] Regulatory perspectives of combination products

J Tian, X Song, Y Wang, M Cheng, S Lu, W Xu, G Gao… - Bioactive Materials, 2022 - Elsevier
Combination products with a wide range of clinical applications represent a unique class of
medical products that are composed of more than a singular medical device or …

[HTML][HTML] Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy

AM Cherian, SV Nair, V Maniyal, D Menon - APL bioengineering, 2021 - pubs.aip.org
Coronary in-stent restenosis and late stent thrombosis are the two major inadequacies of
vascular stents that limit its long-term efficacy. Although restenosis has been successfully …

Theoretical modeling of endovascular drug delivery into a multilayer arterial wall from a drug-coated balloon

A Jain, S McGinty, G Pontrelli, L Zhou - … Journal of Heat and Mass Transfer, 2022 - Elsevier
Drug-coated balloons (DCBs) are used commonly for delivering drug into diseased arteries.
When applied on the inner surface of an artery, drug is transported from the balloon into the …